Literature DB >> 20955728

Synthesis and in vitro evaluation of carboxymethyl starch-chitosan nanoparticles as drug delivery system to the colon.

Mohammad Reza Saboktakin1, Roya M Tabatabaie, Abel Maharramov, Mohammad Ali Ramazanov.   

Abstract

The purpose of this study was to examine chitosan (CS)-carboxymethyl starch (CMS) nanoparticles as drug delivery system to the colon. The 5-aminosalicylic acid (5-ASA) was chosen as model drug molecule. CS-CMS nanoparticles were formulated by a complex coacervation process under mild conditions. The influence of process variables, including the two ionic polymers, on particle size, and nanoparticles entrapment of 5-ASA was studied. In vitro release of 5-ASA was also evaluated, and the integrity of 5-ASA in the release fraction was assessed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The release of 5-ASA from nanoparticle was based on the ion-exchange mechanism. The CS-CMS nanoparticles developed based on the modulation of ratio show promise as a system for controlled delivery of drug to the colon.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955728     DOI: 10.1016/j.ijbiomac.2010.10.005

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  9 in total

Review 1.  Biopolymeric Nanoparticles-Multifunctional Materials of the Future.

Authors:  Andrey A Vodyashkin; Parfait Kezimana; Alexandre A Vetcher; Yaroslav M Stanishevskiy
Journal:  Polymers (Basel)       Date:  2022-06-04       Impact factor: 4.967

Review 2.  A Review on Chitosan's Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment.

Authors:  Rayssa de Sousa Victor; Adillys Marcelo da Cunha Santos; Bianca Viana de Sousa; Gelmires de Araújo Neves; Lisiane Navarro de Lima Santana; Romualdo Rodrigues Menezes
Journal:  Materials (Basel)       Date:  2020-11-06       Impact factor: 3.623

Review 3.  Micro and nanoscale technologies in oral drug delivery.

Authors:  Samad Ahadian; Joel A Finbloom; Mohammad Mofidfar; Sibel Emir Diltemiz; Fatemeh Nasrollahi; Elham Davoodi; Vahid Hosseini; Ioanna Mylonaki; Sivakoti Sangabathuni; Hossein Montazerian; Kirsten Fetah; Rohollah Nasiri; Mehmet Remzi Dokmeci; Molly M Stevens; Tejal A Desai; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2020-07-22       Impact factor: 15.470

Review 4.  Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review.

Authors:  Muzamil Rashid; Veerpal Kaur; Supandeep Singh Hallan; Saurabh Sharma; Neeraj Mishra
Journal:  Saudi Pharm J       Date:  2014-10-22       Impact factor: 4.330

5.  The effect of polymer and CaCl2 concentrations on the sulfasalazine release from alginate-N,O-carboxymethyl chitosan beads.

Authors:  Moslem Tavakol; Ebrahim Vasheghani-Farahani; Sameereh Hashemi-Najafabadi
Journal:  Prog Biomater       Date:  2013-04-04

Review 6.  An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery.

Authors:  Munawar A Mohammed; Jaweria T M Syeda; Kishor M Wasan; Ellen K Wasan
Journal:  Pharmaceutics       Date:  2017-11-20       Impact factor: 6.321

Review 7.  Current development of biodegradable polymeric materials for biomedical applications.

Authors:  Richard Song; Maxwell Murphy; Chenshuang Li; Kang Ting; Chia Soo; Zhong Zheng
Journal:  Drug Des Devel Ther       Date:  2018-09-24       Impact factor: 4.162

Review 8.  Nanochitosan: Commemorating the Metamorphosis of an ExoSkeletal Waste to a Versatile Nutraceutical.

Authors:  Iyyakkannu Sivanesan; Manikandan Muthu; Judy Gopal; Nazim Hasan; Syed Kashif Ali; Juhyun Shin; Jae-Wook Oh
Journal:  Nanomaterials (Basel)       Date:  2021-03-23       Impact factor: 5.076

Review 9.  Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review.

Authors:  M Abd Elgadir; Md Salim Uddin; Sahena Ferdosh; Aishah Adam; Ahmed Jalal Khan Chowdhury; Md Zaidul Islam Sarker
Journal:  J Food Drug Anal       Date:  2014-12-04       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.